Clinical Trials for Anti-PD1 Antibody

Find clinical trials for anti-pd1 antibody. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma

NCT ID: NCT06740370

This clinical trial is looking at a new treatment approach for patients with a specific type of liver cancer called hepatocellular carcinoma (HCC) that has ruptured, causing bleeding. The study is ...

Recruiting

Phase: NA Type: interventional Locations: Beijing, None Selected, China

Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma

NCT ID: NCT06550921

This clinical trial is studying a new approach for treating advanced liver cancer (hepatocellular carcinoma, or HCC) that has spread to a few other areas (oligometastasis). The researchers want to ...

Recruiting

Phase: NA Type: interventional Locations: Beijing, None Selected, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions